Teleflex (TFX) to Release Quarterly Earnings on Thursday

Teleflex (NYSE:TFX) is anticipated to post its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Teleflex to post earnings of $1.28 per share and revenue of $559.5890 million for the quarter. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:00 AM ET.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The firm had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company’s revenue was up 32.3% on a year-over-year basis. During the same quarter last year, the company earned $1.44 EPS. On average, analysts expect Teleflex to post $7 EPS for the current fiscal year and $11 EPS for the next fiscal year.

Teleflex Stock Performance

NYSE:TFX opened at $139.86 on Tuesday. The stock has a fifty day moving average price of $131.11 and a 200-day moving average price of $121.71. The company has a market cap of $6.19 billion, a price-to-earnings ratio of -6.13, a PEG ratio of 1.02 and a beta of 0.81. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $144.19.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were given a $0.34 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Institutional Trading of Teleflex

Several large investors have recently bought and sold shares of the business. UMB Bank n.a. increased its position in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares in the last quarter. Kestra Advisory Services LLC acquired a new position in shares of Teleflex during the fourth quarter worth $45,000. Danske Bank A S acquired a new position in shares of Teleflex during the third quarter worth $54,000. State of Wyoming bought a new position in shares of Teleflex in the 2nd quarter valued at $111,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Teleflex by 108.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after acquiring an additional 521 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

TFX has been the subject of several recent analyst reports. Raymond James Financial reaffirmed an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Wall Street Zen lowered shares of Teleflex from a “hold” rating to a “sell” rating in a report on Saturday. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research report on Wednesday, June 24th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and upped their price target for the stock from $135.00 to $155.00 in a report on Friday, May 8th. Finally, Truist Financial reiterated a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Teleflex currently has a consensus rating of “Hold” and an average price target of $148.90.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.